LT2566972T - Kompozicijos, skirtos cinko pirštu modulių susiejimui - Google Patents
Kompozicijos, skirtos cinko pirštu modulių susiejimuiInfo
- Publication number
- LT2566972T LT2566972T LTEP11777690.6T LT11777690T LT2566972T LT 2566972 T LT2566972 T LT 2566972T LT 11777690 T LT11777690 T LT 11777690T LT 2566972 T LT2566972 T LT 2566972T
- Authority
- LT
- Lithuania
- Prior art keywords
- compositions
- zinc finger
- finger modules
- linking zinc
- linking
- Prior art date
Links
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000011701 zinc Substances 0.000 title 1
- 229910052725 zinc Inorganic materials 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Contacts (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34372910P | 2010-05-03 | 2010-05-03 | |
| PCT/US2011/000758 WO2011139349A1 (en) | 2010-05-03 | 2011-05-02 | Compositions for linking zinc finger modules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2566972T true LT2566972T (lt) | 2020-03-10 |
Family
ID=44903931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP11777690.6T LT2566972T (lt) | 2010-05-03 | 2011-05-02 | Kompozicijos, skirtos cinko pirštu modulių susiejimui |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8772453B2 (lt) |
| EP (2) | EP3636766A1 (lt) |
| JP (1) | JP5898179B2 (lt) |
| KR (2) | KR101974036B1 (lt) |
| CN (1) | CN102959087B (lt) |
| AU (1) | AU2011249019B2 (lt) |
| CA (1) | CA2797189C (lt) |
| CY (1) | CY1122636T1 (lt) |
| DK (1) | DK2566972T3 (lt) |
| ES (1) | ES2773052T3 (lt) |
| HR (1) | HRP20200254T1 (lt) |
| HU (1) | HUE048072T2 (lt) |
| IL (1) | IL222632B (lt) |
| LT (1) | LT2566972T (lt) |
| PL (1) | PL2566972T3 (lt) |
| PT (1) | PT2566972T (lt) |
| SI (1) | SI2566972T1 (lt) |
| WO (1) | WO2011139349A1 (lt) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120196370A1 (en) | 2010-12-03 | 2012-08-02 | Fyodor Urnov | Methods and compositions for targeted genomic deletion |
| JP6050230B2 (ja) | 2010-07-21 | 2016-12-21 | サンガモ バイオサイエンシーズ， インコーポレイテッド | Ｈｌａ遺伝子座の修飾のための方法及び組成物 |
| WO2012094132A1 (en) | 2011-01-05 | 2012-07-12 | Sangamo Biosciences, Inc. | Methods and compositions for gene correction |
| US9161995B2 (en) | 2011-07-25 | 2015-10-20 | Sangamo Biosciences, Inc. | Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene |
| CA3099582A1 (en) | 2011-10-27 | 2013-05-02 | Sangamo Biosciences, Inc. | Methods and compositions for modification of the hprt locus |
| AU2013225950B2 (en) | 2012-02-29 | 2018-02-15 | Sangamo Therapeutics, Inc. | Methods and compositions for treating huntington's disease |
| CA2878037C (en) | 2012-07-11 | 2021-08-31 | Sangamo Biosciences, Inc. | Methods and compositions for delivery of biologics |
| US10648001B2 (en) | 2012-07-11 | 2020-05-12 | Sangamo Therapeutics, Inc. | Method of treating mucopolysaccharidosis type I or II |
| RS60838B1 (sr) | 2012-08-29 | 2020-10-30 | Sangamo Therapeutics Inc | Postupci i kompozicije za tretman genskog stanja |
| WO2014071070A1 (en) | 2012-11-01 | 2014-05-08 | Pacific Biosciences Of California, Inc. | Compositions and methods for selection of nucleic acids |
| US9290800B2 (en) | 2013-03-15 | 2016-03-22 | Pacific Biosciences Of California, Inc. | Targeted rolling circle amplification |
| AU2014248208C1 (en) | 2013-04-05 | 2023-04-27 | Corteva Agriscience Llc | Methods and compositions for integration of an exogenous sequence within the genome of plants |
| AU2014312295C1 (en) | 2013-08-28 | 2020-08-13 | Sangamo Therapeutics, Inc. | Compositions for linking DNA-binding domains and cleavage domains |
| CA2926094C (en) | 2013-10-17 | 2024-04-02 | Sangamo Biosciences, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| EP3057432B1 (en) | 2013-10-17 | 2018-11-21 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells |
| JP2016537341A (ja) | 2013-11-11 | 2016-12-01 | サンガモ バイオサイエンシーズ， インコーポレイテッド | ハンチントン病を処置するための方法および組成物 |
| LT3068881T (lt) | 2013-11-13 | 2019-08-12 | Children`S Medical Center Corporation | Geno raiškos reguliavimas, tarpininkaujant nukleazei |
| DK3102673T3 (da) | 2014-02-03 | 2020-07-06 | Sangamo Therapeutics Inc | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi |
| AU2015231353B2 (en) | 2014-03-18 | 2020-11-05 | Sangamo Therapeutics, Inc. | Methods and compositions for regulation of zinc finger protein expression |
| US10435685B2 (en) | 2014-08-19 | 2019-10-08 | Pacific Biosciences Of California, Inc. | Compositions and methods for enrichment of nucleic acids |
| IL284707B2 (en) | 2015-05-12 | 2024-01-01 | Sangamo Therapeutics Inc | Regulation of nuclease-mediated gene expression |
| US9957501B2 (en) | 2015-06-18 | 2018-05-01 | Sangamo Therapeutics, Inc. | Nuclease-mediated regulation of gene expression |
| CN108024544B (zh) | 2015-07-13 | 2022-04-29 | 桑格摩生物治疗股份有限公司 | 用于核酸酶介导的基因组工程化的递送方法及组合物 |
| AU2016374253B2 (en) | 2015-12-18 | 2021-10-21 | Sangamo Therapeutics, Inc. | Targeted disruption of the MHC cell receptor |
| AU2016369490C1 (en) | 2015-12-18 | 2021-12-23 | Sangamo Therapeutics, Inc. | Targeted disruption of the T cell receptor |
| CA3010738A1 (en) | 2016-01-15 | 2017-07-20 | Sangamo Therapeutics, Inc. | Methods and compositions for the treatment of neurologic disease |
| EP3411056A4 (en) | 2016-02-02 | 2019-10-02 | Sangamo Therapeutics, Inc. | COMPOUNDS FOR NETWORKING DNA BINDING DOMAINS AND SPLITTING DOMAINS |
| CN110418841A (zh) | 2016-08-24 | 2019-11-05 | 桑格摩生物治疗股份有限公司 | 工程化的靶特异性核酸酶 |
| JP7203014B2 (ja) | 2016-08-24 | 2023-01-12 | サンガモ セラピューティクス， インコーポレイテッド | 工学操作されたヌクレアーゼを使用した遺伝子発現の調節 |
| WO2018075736A1 (en) | 2016-10-20 | 2018-04-26 | Sangamo Therapeutics, Inc. | Methods and compositions for the treatment of fabry disease |
| CA3041668A1 (en) | 2016-10-31 | 2018-05-03 | Sangamo Therapeutics, Inc. | Gene correction of scid-related genes in hematopoietic stem and progenitor cells |
| AU2017367722B2 (en) | 2016-12-01 | 2024-02-01 | Sangamo Therapeutics, Inc. | Tau modulators and methods and compositions for delivery thereof |
| CN110730823B (zh) | 2017-04-03 | 2023-12-29 | 编码治疗公司 | 组织选择性转基因表达 |
| WO2018200943A1 (en) | 2017-04-28 | 2018-11-01 | Acuitas Therapeutics, Inc. | Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| US11655275B2 (en) | 2017-05-03 | 2023-05-23 | Sangamo Therapeutics, Inc. | Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene |
| US11512287B2 (en) | 2017-06-16 | 2022-11-29 | Sangamo Therapeutics, Inc. | Targeted disruption of T cell and/or HLA receptors |
| EP3706766A4 (en) | 2017-11-09 | 2021-08-18 | Sangamo Therapeutics, Inc. | GENETIC MODIFICATION OF THE CYTOCINE INDUCTIBLE SH2-CONTAINING PROTEIN (CISH) GENE |
| AU2019218118A1 (en) | 2018-02-08 | 2020-08-13 | Sangamo Therapeutics, Inc. | Engineered target specific nucleases |
| US11421007B2 (en) * | 2018-04-18 | 2022-08-23 | Sangamo Therapeutics, Inc. | Zinc finger protein compositions for modulation of huntingtin (Htt) |
| US11690921B2 (en) | 2018-05-18 | 2023-07-04 | Sangamo Therapeutics, Inc. | Delivery of target specific nucleases |
| WO2020041249A1 (en) | 2018-08-23 | 2020-02-27 | Sangamo Therapeutics, Inc. | Engineered target specific base editors |
| CA3111711A1 (en) | 2018-09-18 | 2020-03-26 | Sangamo Therapeutics, Inc. | Programmed cell death 1 (pd1) specific nucleases |
| EP3861130A4 (en) * | 2018-10-02 | 2022-08-03 | Sangamo Therapeutics, Inc. | GENETIC MODULATORS |
| BR112021013654A2 (pt) | 2019-01-11 | 2021-09-14 | Acuitas Therapeutics, Inc. | Lipídeos para liberação de nanopartículas lipídicas de agentes ativos |
| CA3106693A1 (en) | 2019-02-06 | 2020-08-13 | Sangamo Therapeutics, Inc. | Method for the treatment of mucopolysaccharidosis type i |
| CN115141807A (zh) | 2019-04-02 | 2022-10-04 | 桑格摩生物治疗股份有限公司 | 治疗β-地中海贫血症的方法 |
| EP3958871A1 (en) | 2019-04-23 | 2022-03-02 | Sangamo Therapeutics, Inc. | Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof |
| WO2021028359A1 (en) | 2019-08-09 | 2021-02-18 | Sangamo Therapeutics France | Controlled expression of chimeric antigen receptors in t cells |
| WO2021067871A1 (en) | 2019-10-02 | 2021-04-08 | Sangamo Therapeutics, Inc. | Zinc finger protein transcription factors for repressing alpha-synuclein expression |
| EP4041271A1 (en) | 2019-10-02 | 2022-08-17 | Sangamo Therapeutics, Inc. | Zinc finger protein transcription factors for treatment of prion disease |
| CN115279419A (zh) | 2019-11-01 | 2022-11-01 | 美商圣加莫治疗股份有限公司 | 用于基因组工程的组合物和方法 |
| US20230242602A1 (en) | 2020-01-22 | 2023-08-03 | Sangamo Therapeutics, Inc. | Zinc finger protein transcription factors for repressing tau expression |
| IL299787A (en) | 2020-07-16 | 2023-03-01 | Acuitas Therapeutics Inc | Cationic lipids for use in lipid nanoparticles |
| WO2022046760A2 (en) | 2020-08-25 | 2022-03-03 | Kite Pharma, Inc. | T cells with improved functionality |
| EP4217479A1 (en) | 2020-09-25 | 2023-08-02 | Sangamo Therapeutics, Inc. | Zinc finger fusion proteins for nucleobase editing |
| UY39450A (es) | 2020-10-02 | 2022-04-29 | Sangamo Therapeutics Inc | Nuevos factores de transcripción de la proteína de dedo de zinc para reprimir la expresión de alfa- sinucleina |
| EP4267743A2 (en) | 2020-12-22 | 2023-11-01 | Chroma Medicine, Inc. | Compositions and methods for epigenetic editing |
| CA3237482A1 (en) | 2021-11-03 | 2023-05-11 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Precise genome editing using retrons |
| CA3241193A1 (en) | 2021-12-22 | 2023-06-29 | Friedrich A. FAUSER | Novel zinc finger fusion proteins for nucleobase editing |
| WO2023141602A2 (en) | 2022-01-21 | 2023-07-27 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| WO2023215711A1 (en) | 2022-05-01 | 2023-11-09 | Chroma Medicine, Inc. | Compositions and methods for epigenetic regulation of pcsk9 expression |
| WO2023250490A1 (en) | 2022-06-23 | 2023-12-28 | Chroma Medicine, Inc. | Compositions and methods for epigenetic regulation of trac expression |
| WO2023250512A1 (en) | 2022-06-23 | 2023-12-28 | Chroma Medicine, Inc. | Compositions and methods for epigenetic regulation of ciita expression |
| WO2023250509A1 (en) | 2022-06-23 | 2023-12-28 | Chroma Medicine, Inc. | Compositions and methods for epigenetic regulation of b2m expression |
| WO2024044723A1 (en) | 2022-08-25 | 2024-02-29 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
| WO2024064910A1 (en) | 2022-09-23 | 2024-03-28 | Chroma Medicine, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2024081879A1 (en) | 2022-10-14 | 2024-04-18 | Chroma Medicine, Inc. | Compositions and methods for epigenetic regulation of cd247 expression |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4512110A (en) | 1981-12-10 | 1985-04-23 | Timesavers, Inc. | Endless abrasive belts |
| US5422251A (en) | 1986-11-26 | 1995-06-06 | Princeton University | Triple-stranded nucleic acids |
| US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5356802A (en) | 1992-04-03 | 1994-10-18 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease |
| US5487994A (en) | 1992-04-03 | 1996-01-30 | The Johns Hopkins University | Insertion and deletion mutants of FokI restriction endonuclease |
| US5436150A (en) | 1992-04-03 | 1995-07-25 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US6242568B1 (en) | 1994-01-18 | 2001-06-05 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| AU704601B2 (en) | 1994-01-18 | 1999-04-29 | Scripps Research Institute, The | Zinc finger protein derivatives and methods therefor |
| US5585245A (en) | 1994-04-22 | 1996-12-17 | California Institute Of Technology | Ubiquitin-based split protein sensor |
| US7285416B2 (en) | 2000-01-24 | 2007-10-23 | Gendaq Limited | Regulated gene expression in plants |
| GB9824544D0 (en) | 1998-11-09 | 1999-01-06 | Medical Res Council | Screening system |
| US6007988A (en) | 1994-08-20 | 1999-12-28 | Medical Research Council | Binding proteins for recognition of DNA |
| US5789538A (en) | 1995-02-03 | 1998-08-04 | Massachusetts Institute Of Technology | Zinc finger proteins with high affinity new DNA binding specificities |
| US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| GB2338237B (en) | 1997-02-18 | 2001-02-28 | Actinova Ltd | In vitro peptide or protein expression library |
| US6342345B1 (en) | 1997-04-02 | 2002-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of molecular interactions by reporter subunit complementation |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| US6410248B1 (en) | 1998-01-30 | 2002-06-25 | Massachusetts Institute Of Technology | General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites |
| ATE466952T1 (de) | 1998-03-02 | 2010-05-15 | Massachusetts Inst Technology | Poly-zinkfinger-proteine mit verbesserten linkern |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6599692B1 (en) | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
| US7151201B2 (en) * | 2000-01-21 | 2006-12-19 | The Scripps Research Institute | Methods and compositions to modulate expression in plants |
| CA2398155C (en) | 2000-01-24 | 2011-07-19 | Sangamo Biosciences, Inc. | Methods and compositions for linking binding domains in nucleic acid binding proteins |
| EP1254369B1 (en) | 2000-02-08 | 2010-10-06 | Sangamo BioSciences, Inc. | Cells for drug discovery |
| US20020061512A1 (en) | 2000-02-18 | 2002-05-23 | Kim Jin-Soo | Zinc finger domains and methods of identifying same |
| US20030044787A1 (en) | 2000-05-16 | 2003-03-06 | Joung J. Keith | Methods and compositions for interaction trap assays |
| US20060268407A1 (en) | 2000-07-07 | 2006-11-30 | Fergason James L | Display system using two displays and polarization direction rotation for showing high-resolution and three-dimensional images and method and use of a DBEF beam splitter |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| US7067317B2 (en) | 2000-12-07 | 2006-06-27 | Sangamo Biosciences, Inc. | Regulation of angiogenesis with zinc finger proteins |
| US20040197892A1 (en) | 2001-04-04 | 2004-10-07 | Michael Moore | Composition binding polypeptides |
| GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| US20040224385A1 (en) | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| US7262054B2 (en) | 2002-01-22 | 2007-08-28 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
| EP1532178A4 (en) | 2002-06-11 | 2006-10-25 | Scripps Research Inst | ARTIFICIAL TRANSCRIPTION FACTORS |
| US8409861B2 (en) | 2003-08-08 | 2013-04-02 | Sangamo Biosciences, Inc. | Targeted deletion of cellular DNA sequences |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| CA2539439C (en) * | 2003-09-19 | 2012-10-23 | Sangamo Biosciences, Inc. | Engineered zinc finger proteins for regulation of gene expression |
| WO2005061705A1 (en) | 2003-12-23 | 2005-07-07 | Toolgen, Inc. | Regulation of prokaryotic gene expression with zinc finger proteins |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| EP1737498A2 (en) | 2004-04-08 | 2007-01-03 | Sangamo Biosciences Inc. | Zinc finger proteins for treatment of neuropathic pain |
| KR20070060115A (ko) | 2004-09-16 | 2007-06-12 | 상가모 바이오사이언스 인코포레이티드 | 단백질 생산을 위한 조성물 및 방법 |
| US20090068164A1 (en) | 2005-05-05 | 2009-03-12 | The Ariz Bd Of Regents On Behald Of The Univ Of Az | Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences |
| KR20080033455A (ko) | 2005-07-26 | 2008-04-16 | 상가모 바이오사이언스 인코포레이티드 | 외래 핵산 서열의 표적화된 통합 및 발현 |
| ES2602184T3 (es) | 2005-10-18 | 2017-02-20 | Precision Biosciences | Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas |
| EP2018424A2 (en) | 2006-05-19 | 2009-01-28 | Sangamo BioSciences, Inc. | Methods and compositions for inactivation of dihydrofolate reductase |
| EP2027262B1 (en) | 2006-05-25 | 2010-03-31 | Sangamo Biosciences Inc. | Variant foki cleavage half-domains |
| ATE536371T1 (de) | 2006-05-25 | 2011-12-15 | Sangamo Biosciences Inc | Verfahren und zusammensetzungen zur gendeaktivierung |
| JP5188504B2 (ja) | 2006-11-13 | 2013-04-24 | サンガモ バイオサイエンシズ インコーポレイテッド | ヒトグルココルチコイド受容体遺伝子座の修飾のための方法および組成物 |
| DE602008003684D1 (de) | 2007-04-26 | 2011-01-05 | Sangamo Biosciences Inc | Gezielte integration in die ppp1r12c-position |
| EP2188384B1 (en) | 2007-09-27 | 2015-07-15 | Sangamo BioSciences, Inc. | Rapid in vivo identification of biologically active nucleases |
| CA2767377A1 (en) * | 2009-07-24 | 2011-01-27 | Sigma-Aldrich Co. Llc | Method for genome editing |
-
2011
- 2011-05-02 KR KR1020187017770A patent/KR101974036B1/ko active IP Right Grant
- 2011-05-02 PT PT117776906T patent/PT2566972T/pt unknown
- 2011-05-02 AU AU2011249019A patent/AU2011249019B2/en active Active
- 2011-05-02 HU HUE11777690A patent/HUE048072T2/hu unknown
- 2011-05-02 ES ES11777690T patent/ES2773052T3/es active Active
- 2011-05-02 DK DK11777690.6T patent/DK2566972T3/da active
- 2011-05-02 PL PL11777690T patent/PL2566972T3/pl unknown
- 2011-05-02 SI SI201131844T patent/SI2566972T1/sl unknown
- 2011-05-02 WO PCT/US2011/000758 patent/WO2011139349A1/en active Application Filing
- 2011-05-02 EP EP19211724.0A patent/EP3636766A1/en active Pending
- 2011-05-02 US US13/068,102 patent/US8772453B2/en active Active
- 2011-05-02 LT LTEP11777690.6T patent/LT2566972T/lt unknown
- 2011-05-02 CN CN201180022329.2A patent/CN102959087B/zh active Active
- 2011-05-02 CA CA2797189A patent/CA2797189C/en active Active
- 2011-05-02 EP EP11777690.6A patent/EP2566972B1/en active Active
- 2011-05-02 JP JP2013509041A patent/JP5898179B2/ja active Active
- 2011-05-02 KR KR1020127028770A patent/KR20130073887A/ko not_active Application Discontinuation
-
2012
- 2012-10-23 IL IL222632A patent/IL222632B/en active IP Right Grant
-
2014
- 2014-06-04 US US14/296,159 patent/US9163245B2/en active Active
-
2020
- 2020-02-14 CY CY20201100140T patent/CY1122636T1/el unknown
- 2020-02-14 HR HRP20200254TT patent/HRP20200254T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2797189A1 (en) | 2011-11-10 |
| US8772453B2 (en) | 2014-07-08 |
| EP2566972B1 (en) | 2020-01-15 |
| US20140287500A1 (en) | 2014-09-25 |
| KR20130073887A (ko) | 2013-07-03 |
| US20110287512A1 (en) | 2011-11-24 |
| CY1122636T1 (el) | 2021-03-12 |
| CN102959087B (zh) | 2015-04-29 |
| DK2566972T3 (da) | 2020-02-17 |
| JP2013527765A (ja) | 2013-07-04 |
| JP5898179B2 (ja) | 2016-04-06 |
| PT2566972T (pt) | 2020-03-02 |
| EP2566972A1 (en) | 2013-03-13 |
| WO2011139349A1 (en) | 2011-11-10 |
| SI2566972T1 (sl) | 2020-04-30 |
| US9163245B2 (en) | 2015-10-20 |
| ES2773052T3 (es) | 2020-07-09 |
| IL222632A0 (en) | 2012-12-31 |
| AU2011249019B2 (en) | 2015-01-22 |
| KR101974036B1 (ko) | 2019-04-30 |
| KR20180077284A (ko) | 2018-07-06 |
| PL2566972T3 (pl) | 2020-06-29 |
| CN102959087A (zh) | 2013-03-06 |
| EP3636766A1 (en) | 2020-04-15 |
| IL222632B (en) | 2018-12-31 |
| HRP20200254T1 (hr) | 2020-05-29 |
| EP2566972A4 (en) | 2014-01-01 |
| CA2797189C (en) | 2020-05-26 |
| HUE048072T2 (hu) | 2020-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL222632A0 (en) | Compositions for linking zinc finger modules | |
| HRP20181658T1 (hr) | Kruti pripravci | |
| HK1243746A1 (zh) | 組合物 | |
| ZA201207093B (en) | Solid compositions | |
| GB201009549D0 (en) | Compositions | |
| GB201010954D0 (en) | Compositions | |
| GB201002861D0 (en) | Compositions | |
| EP2625231A4 (en) | INK PRESERVATIVE COMPOSITIONS | |
| IL225952A0 (en) | preparations@rokkhot | |
| GB201014591D0 (en) | Compositions | |
| GB201007790D0 (en) | Compositions | |
| GB201019606D0 (en) | Compositions | |
| GB201008043D0 (en) | Compositions | |
| TWM385393U (en) | Linking component | |
| GB201012508D0 (en) | Compositions | |
| GB201012588D0 (en) | Compositions | |
| GB201008369D0 (en) | Compositions | |
| GB201012760D0 (en) | MustPush rake |